Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RXRX Recursion Pharmaceuticals, Inc.

Trading 10-08 15:43:55 EDT

3.91

-0.36

-8.37%

High4.20	Low3.79	Vol24.20M
Open4.20	D1 Closing4.27	Amplitude9.60%
Mkt Cap2.09B	Tradable Cap2.04B	Total Shares535.00M
T/O94.75M	T/O Rate4.63%	Tradable Shares522.33M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":3.9125,"timestamp":1791488633981,"preClose":4.27,"halted":0,"volume":24197142,"delay":0,"changeRate":-0.08372365339578443,"floatShares":522325546,"shares":534999999,"eps":-1.021913,"marketStatus":"Trading","change":-0.3575,"latestTime":"10-08 15:43:55 EDT","open":4.2,"high":4.2,"low":3.79,"amount":94745366.1689484,"amplitude":0.096019,"askPrice":3.92,"askSize":10268,"bidPrice":3.91,"bidSize":26922,"shortable":0,"etf":0,"ttmEps":-1.021913,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791489600000},"marketStatusCode":2,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":4.27,"preHourTrading":{"tag":"盘前","latestPrice":4.18,"preClose":4.27,"latestTime":"09:29 EDT","volume":305011,"amount":1278017.135759,"timestamp":1791466199999,"change":-0.09,"changeRate":-0.021077,"amplitude":0.035129},"postHourTrading":{"tag":"盘后","latestPrice":4.27,"preClose":4.27,"latestTime":"19:59 EDT","volume":738666,"amount":3157468.4912,"timestamp":1791417583380,"change":0,"changeRate":0,"amplitude":0.021077},"volumeRatio":0.585602,"impliedVol":0.9583,"impliedVolPercentile":0.6932},"requestUrl":"/m/hq/s/RXRX/","defaultTab":"news","newsList":[{"id":"1188778479","title":"Movement Alert｜Recursion Pharmaceuticals, Inc. Falls 8.08% in Regular Trading, Insider Selling and Amended Tempus AI Agreement Weigh on Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1188778479","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188778479?lang=en_us&edition=fundamental","pubTime":"2026-10-08 22:53","pubTimestamp":1791471189,"startTime":"0","endTime":"0","summary":"On October 8, Recursion Pharmaceuticals, Inc. fell 8.08% in regular trading, trading at $3.9111/share, with Turnover of $38.0443 million.The decline followed disclosures that the company's amended...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673044266","title":"Top Recursion Pharma Insider Makes a Major Move With His Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673044266","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673044266?lang=en_us&edition=fundamental","pubTime":"2026-10-08 10:02","pubTimestamp":1791424936,"startTime":"0","endTime":"0","summary":"New insider activity at Recursion Pharmaceuticals ( ($RXRX) ) has taken place on October 7, 2026. Director Robert Hershberg of Recursion Pharmaceut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-recursion-pharma-insider-makes-a-major-move-with-his-shares-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-recursion-pharma-insider-makes-a-major-move-with-his-shares-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4609","BK4548","BK4139","BK4611","RXRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673462030","title":"Cathie Wood’s ARK Investment buys 1.9M shares of Recursion Pharmaceuticals today","url":"https://stock-news.laohu8.com/highlight/detail?id=2673462030","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673462030?lang=en_us&edition=fundamental","pubTime":"2026-10-08 08:05","pubTimestamp":1791417919,"startTime":"0","endTime":"0","summary":"20:03 EDT Cathie Wood’s ARK Investment buys 1.9M shares of Recursion Pharmaceuticals (RXRX) today Published first on TheFly – the ultimate source f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-1-9m-shares-of-recursion-pharmaceuticals-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-1-9m-shares-of-recursion-pharmaceuticals-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKK","BK4539","BK4588","BK4585","BK4548","BK4609","RXRX","BK4611","BK4544","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673904321","title":"Recursion Director Robert Hershberg Sells 25,000 Common Shares for $125,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2673904321","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673904321?lang=en_us&edition=fundamental","pubTime":"2026-10-08 06:08","pubTimestamp":1791410934,"startTime":"0","endTime":"0","summary":"Recursion director Robert Hershberg sells 25,000 common shares for $125,000Recursion Pharmaceuticals director Robert Hershberg exercised stock options for 25,000 Class A shares at USD 2.22 on Oct. 6, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL3gsgPS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Recursion Director Robert Hershberg Sells 25,000 Common Shares for $125,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX","BK4139","BK4539","BK4548","BK4611","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133823123","title":"Movement Alert｜Recursion Pharmaceuticals, Inc. Falls 8.21% in Regular Trading, Tempus Data License Amendment Spurs Market Divergence","url":"https://stock-news.laohu8.com/highlight/detail?id=1133823123","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133823123?lang=en_us&edition=fundamental","pubTime":"2026-10-08 01:31","pubTimestamp":1791394292,"startTime":"0","endTime":"0","summary":"On October 8, Recursion Pharmaceuticals, Inc. fell 8.21% in regular trading, trading at $4.245 per share, with turnover of $120 million.The decline follows last month's amended data license agreement...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Recursion Drops as Tempus License Amendment Limits Flexibility","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673804700","title":"Cathie Wood’s ARK Investment buys 1.5M shares of Recursion Pharmaceuticals today","url":"https://stock-news.laohu8.com/highlight/detail?id=2673804700","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673804700?lang=en_us&edition=fundamental","pubTime":"2026-10-06 08:25","pubTimestamp":1791246309,"startTime":"0","endTime":"0","summary":"20:24 EDT Cathie Wood’s ARK Investment buys 1.5M shares of Recursion Pharmaceuticals (RXRX) today Published first on TheFly – the ultimate source f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-1-5m-shares-of-recursion-pharmaceuticals-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-1-5m-shares-of-recursion-pharmaceuticals-today-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","RXRX","BK4548","BK4539","BK4609","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673821610","title":"NASD Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2673821610","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673821610?lang=en_us&edition=fundamental","pubTime":"2026-10-06 05:44","pubTimestamp":1791236640,"startTime":"0","endTime":"0","summary":"Warner Bros. Discovery A     WBD   433,482,653     30.95     0.01      0.03. Direxion TSLA Bull 2X       TSLL    65,607,686     10.21     0.41      4.18. Leverage 2X Lg TSLA Dly     TSLG    63,696,296      5.12     0.21      4.28. GrShr 2x Sh NVDA Daily       NVD    57,348,169      3.31    -0.14     -4.06. iSh 20+ Year Treasury Bd     TLT    48,907,053     77.11    -0.37     -0.48. American Airlines Group      AAL    42,982,871     12.83    -0.11     -0.85. ProSh UltraPro Shrt QQQ     SQQQ    41,253,223     32.25    -0.87     -2.63. ProShares UltraPro QQQ      TQQQ    36,246,701     83.12     2.11      2.60","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1951198990.SGD","LU2360032135.SGD","IE0009356076.USD","AMZG","LU0234570918.USD","LU1551013425.SGD","LU1066051498.USD","LU0354030511.USD","LU2092937148.SGD","LU0053666078.USD","LU1674673428.USD","LU0061474960.USD","LU0210528500.USD","LU2213496289.HKD","AIQ","LU2452424414.USD","LU2403377893.USD","LU2413666426.HKD","CRSH","LU2357627491.SGD","SHY","IE00B775SV38.USD","AMZP","LU0203201768.USD","LU2023250504.SGD","BK4125","BK4559","IE000ITXATA3.USD","LU0234572021.USD","BK4585","LU1989772923.USD","SG9999018865.SGD","LU1116320901.HKD","IE0004091025.USD","LU0708995401.HKD","LU0048573561.USD","LU1923622614.USD","IE00B1XK9C88.USD","NVIW.SI","LU1868836757.USD","LU2065171402.SGD","WISE","TSLL","SINTCmain","LU0348723411.USD","LU1935042488.USD","LU0965509010.AUD","BK4609","LU0251132253.USD","LU0056508442.USD","USXF","LU1261432733.SGD","LU2491050071.SGD","LU0795875086.SGD","LU1880398471.USD","NFLX","BK4566","09766","AMZU","HK0000306701.USD","LU0143551892.USD","LU2237957811.SGD","LU2458330243.SGD","TSLP","LU2272731600.USD","SNVD.UK","ANV","BWX","LU1267930573.SGD","IE000YTNTUN2.SGD","FDTX","BK4549","LU2394011477.USD","IE00BMPRXN33.USD","LU1429558221.USD","LU0882574139.USD","IEF","LU1202635105.USD","LU0133085943.USD","LU1934455194.USD","SG9999002406.SGD","LU1941712264.USD","07522","LU2092627202.USD","BK4538","LU0048584097.USD","LU2505996509.AUD","BK4110","BK4574","INYY","SAMZNmain","IE00BKDWB100.SGD","09834","BBLB","SHOC","AMAA","LU0477156953.USD","FAI","IE000WAW04H5.SGD","ROM","GAMR","RTH","TLTX","LU0130102774.USD","LU0310800379.SGD","LU2054465674.USD","07568","LU2290526834.HKD","LU2764263039.SGD","NVD","LU1051769294.HKD","NVDL","LU0823434740.USD","LU2125909593.SGD","LU0979878070.USD","NVDG","LU0648000940.SGD","LU1127390331.HKD","LU2125910500.SGD","LU0127658192.USD","LU0072462426.USD","BK4503","AMZW",".IXIC","AMZZ","LU0868494617.USD","SG9999013478.USD","07266","LU1935042215.USD","ESLG","LU0823411888.USD","LU1496350171.SGD","NVDB","LU1989764748.USD","BK4527","IE00BFXG0V08.USD","LU1066051811.HKD","LU2750360997.AUD","TSLW","LU0312595415.SGD","TQQY","3NVD.UK","IE00B4JS1V06.HKD","LU0347712357.USD","LU2552382132.HKD","NVDA","LU2347655156.SGD","LU2473716301.USD","LU2931357623.SGD","IE0034235295.USD","LU1992135399.USD","DIPS","LU0553294199.USD","TLT","LU1923623000.USD","LU0302445910.USD","LU0106261372.USD","LU2083900584.USD","LU1935043452.HKD","LU1400636657.SGD","LU1712237335.SGD","LU0823421416.USD","LU0395794307.EUR","LU1548497426.USD","CLSE","ILDR","SG9999001135.SGD","LU0079474960.USD","LU2362540622.SGD","METV","LU2491049909.HKD","LU2023251221.USD","LU2294711713.HKD","LU2111349929.HKD","07261","IE00B5949003.HKD","IGOV","ESUM","LU0651947912.USD","HK0000306685.HKD","BK4532","DVDN","ARTY","LU0532188223.SGD","LU0082616367.USD","09366","IE00BN29S564.USD","QID","IE0002270589.USD","LU1064131342.USD","LU2077746001.SGD","03086","LU0289941410.SGD","LU2063271972.USD","LU2360107168.USD","BK4593","LU2108987350.USD","IXN","LU0196696701.USD","NVDQ","LU0274383776.USD","SQQQ","NFLP","FTXL","CNEQ","CRDT","IE000SO60NU8.SGD","LU0323239441.USD","NULC","BK4507","LU2430703095.HKD","LU2896262040.SGD","AGNC","BK4548","LU1316542783.SGD","LU2242650005.HKD","LU2430703251.USD","NFX","TSLZ","09388","07366","LU2125154778.USD","BK4539","LU1861217088.USD","LU0724617625.USD","TLH","TSL","LU0823421333.USD","QMAR","LU0128525929.USD","LU1674673691.USD","LU1989764664.SGD","LU0210637038.USD","LU0531971322.HKD","LU0784383803.USD","LU1037948541.HKD","LU0289960550.SGD","LU1803068979.SGD","LU0672654240.SGD","LU2047632596.USD","TESL","LU0949170772.SGD","LU0868494708.USD","LU2279689827.SGD","LU2168563687.JPY","LU0149725797.USD","LU1496350502.SGD","LU1821325948.USD","IE000M9KFDE8.USD","LU0130517989.USD","LU2505996681.GBP","TSDD","LU2420271590.USD","LU2097829019.USD","HK0000914686.HKD","LU0256863811.USD","NFLW","LU2720916845.USD","LU0708994859.HKD","MORT","LU0323591593.USD","LU2506951792.HKD","BK4529","SGXZ58947870.SGD","LU0689472784.USD","LU0965509101.SGD","BK4535","LU1642822529.SGD","LU1823568750.SGD","LU0109392836.USD","LU0823414551.USD","LU2487616109.SGD","LU0080751232.USD","NFXS","LU0077335932.USD","LU0345769631.USD","SGXZ23171101.USD","TESC","LU1861220033.SGD","LU2264538146.SGD","LU2089985449.USD","TQQQ","LU1852331112.SGD","LU0210536198.USD","BK4511","LU0109391861.USD","LU0949170426.SGD","LU3102509885.SGD","SGXZ99366536.SGD","LU0057025933.USD","RXRX","WBD","TLTW","LU2326559502.SGD","LU0081259029.USD","LU1323610961.USD","LU0345774391.USD","HK0000304805.HKD","LU1941712348.USD","AMZN","LU0985320562.USD","LU1815333072.USD","LU0096364046.USD","LU0345769128.USD","LU2125909916.SGD","LU2764262908.HKD","LU1629891620.HKD","LU0557290698.USD","LU0820561818.USD","LU2125909247.SGD","TYLG","LU1951200564.SGD","IE00BWXC8680.SGD","LU2265009873.SGD","LU2249611893.SGD","LU1515016050.SGD","AIPI","IETC","BK4554","LU2347655073.USD","LU2462591350.SGD","IE00BQXX3F31.USD","NVDY","QDEC","BK4099","LU0061474705.USD","LU0957808578.USD","QQQM","SG9999015986.USD","LU2462157665.USD","LU0061475181.USD","IE00B19Z9505.USD","LU1366333091.USD","DRIV","LU0072461881.USD","NVDU","IE00BDRTCR15.USD","LU1732800096.USD","LU0187121727.USD","LU2237443549.SGD","LU2491050154.USD","LU2272731865.HKD","LU2237957902.USD","ABFL","LU0345768153.USD","LU0390134368.USD","TSLQ","SG9999001077.SGD","AIFD","LU2097344357.USD","BK4230","LU0965509283.SGD","SG9999014898.SGD","LU2237443895.HKD","IE00BDCRKT87.USD","TEST","TTEQ","LU0316494557.USD","LU0354030438.USD","LU1035773651.USD","LU1074936037.SGD","TSLI","BK4220","QQQ","IE000F7OJYX1.SGD","03455","LU2133065610.SGD","LU0898699433.AUD","LU0011850046.USD","LU0640476718.USD","LU2237443382.USD","03034","BK4555","SG9999014914.USD","NVDO","LU2097344431.USD","LU1979441026.SGD","NVC","LU1003077747.HKD","LU2361044949.HKD","LU2168564222.USD","BK4543","LU0441851309.USD","LU0047713382.USD","LU0528227936.USD","CHAT","LU0124676726.USD","LU1720051017.SGD","LU0211327993.USD","LU2471134879.HKD","SG9999006266.SGD","AZYY","XNTK","BK4022","IE00BFSS7M15.SGD","LU0494093205.USD","XLC","LU2236285917.USD","LU0175139822.USD","LU0289961442.SGD","LU2637965513.SGD","QQQX","SOXY","TSLO","LU0211328371.USD","IE00BD6J9T35.USD","LU0417517546.SGD","LU2250418816.HKD","SG9999014575.USD","LU2317271919.USD","IE00BSNM7G36.USD","LU1400636574.HKD","LU0511384066.AUD","LU0889565833.HKD","LU2471134796.USD","NFLY","BK4588","IE0004445239.USD","LU1235294995.USD","BK4550","IE000MB6IJN5.SGD","IE00B775H168.HKD","INTW","LU2322448791.USD","LU0980610538.SGD","NFLU","LU0742534661.SGD","LU0265550946.USD","LU2087625088.SGD","SMHX","LU2999663052.SGD","LU2954938101.SGD","IE00BZ1G4Q59.USD","LU1623119135.USD","LU0266013472.USD","USAW.SI","WANT","LU0029864427.USD","LU1201861249.SGD","LEGR","LU2275660780.HKD","IE0004445015.USD","SGOV","BK4127","ELOL","LU0050427557.USD","SOFI","IE000W1ABFV2.USD","BBIB","LU0265550359.USD","BK4592","IE00BQXX3C00.GBP","NVD3.UK","CHPX","PSQ","SGXZ44715902.SGD","LU1803068623.USD","SG9999018857.SGD","LU2237443465.HKD","LU2168564065.EUR","IE0001KFT4U8.USD","BBSB","LU0820561909.HKD","LU0072463663.USD","LU2028103732.USD","LU0310799852.SGD","LU0342679015.USD","LU2211815571.USD","LU0251131958.USD","LU0276348264.USD","BK4608","LU0289739343.SGD","LU0786609619.USD","FCOM","SG9999017495.SGD","04335","SHV","LU0964807845.USD","LU1791710400.SGD","IE00BJJMRX11.SGD","LU0943347566.SGD","LU0321505439.SGD","LU1116320737.USD","IE0000B7K699.USD","LU0965508806.USD","LU1119994496.HKD","LU1435385759.SGD","LU0912757837.SGD","LU0196696453.USD","IE00BJLML261.HKD","NVDW","LU2087621335.USD","BK4500","LU1633808545.USD","LU1718418525.SGD","LU1934455277.USD","LU1144417596.USD","LU1992135472.HKD","SG9999014880.SGD","GXPC","LU2433249047.HKD","LU2168564495.EUR","BK4515","LU1721428933.USD","LU1935043023.USD","LFGY","LU2746668974.SGD","IE0034235303.USD","LU0726765562.USD","SGXZ80539844.SGD","LU0444971666.USD","LU0069063385.USD","LU0320765489.SGD","BK4598","LU1035775433.USD","BK4008","IE00BMPRXR70.SGD","LU1046421795.USD","LU1691799644.USD","SG9999000418.SGD","LU0784384876.USD","LU1400636491.USD","LU1732799900.SGD","TLTI","LU1280957306.USD","LU0070302665.USD","AMZO","WATS","2NVD.UK","NVYY","SMH","LU2237443622.USD","BK4534","LU0719512351.SGD","SG9999001424.SGD","NOCT","IE00B5TLWC47.USD","LU0094547139.USD","LU2592432038.USD","CMAG","IE00BMPRXQ63.HKD","LU0861579265.USD","IE00B19Z3B42.SGD","LU0251142724.SGD","LU1084165304.USD","SNPE","BK4122","SPTE","LU1699723380.USD","07766","LU1934455863.HKD","NVD2.UK","SGXZ51526630.SGD","SOXX","SG9999002232.USD","IE000BZT7R73.USD","LU1366192091.USD","LU0157215616.USD","LU0942090050.USD","GPIQ","LU0215105999.USD","BK4596","LU1551013342.USD","LU0345770308.USD","LU1244550494.USD","IE00BJTD4V19.USD","INT","IE00BZ199S13.USD","LU1815336760.USD","AMZD","IE0005OL40V9.USD","ALEC","LU1839511570.USD","LU2361045086.USD","LU2750360641.GBP","SG9999002414.USD","LU0256863902.USD","LU0320765059.SGD","LU1242518857.USD","USD","LU1066051225.USD","SG9999014542.SGD","LU2362541513.USD","IE00BKPKM429.USD","LIT","LU2023250330.USD","BK4166","TFJL","LU2168564149.EUR","LU0545039389.USD","LU0456855351.SGD","LU0107464264.USD","LU1778281490.HKD","LU0738911758.USD","IE00B19Z8X17.USD","LU0162691827.USD","LU2357305700.SGD","LU2471134952.CNY","SG9999015358.SGD","LU2322448957.HKD","LU2461242641.AUD","LU2381873111.SGD","LU1861558580.USD","LU2756315318.SGD","IE00B4YYXB79.USD","LU0210533765.USD","LU1244550221.USD","REM","BK4587","LU0859254822.USD","SOXQ","LU2357125470.USD","IE00B7SZLL34.SGD","TRFK","BK4611","LINT","LU2430703178.SGD","QQQA","SNFLXmain","LU1989772840.SGD","IE00B3SWFQ91.USD","NVDD","LU2148611432.USD","AAL","LU0314104364.USD","LU0444973449.USD","LU0661504455.SGD","SGXZ81514606.USD","SG9999015341.SGD","LU0683600562.USD","VGT","JGRO","LU0170899867.USD","IE00B19Z8W00.USD","LU1670756490.USD","IE00B1BXHZ80.USD","IE00BQXX3D17.EUR","LU1935042991.SGD","LU1868837300.USD","SG9999014906.USD","LU0323240290.USD","LU0006306889.USD","TSYW","LU0795875169.SGD","IE00B3M56506.USD","IE00BK4W5L77.USD","LU2271345857.HKD","LU2456880835.USD","SG9999014567.USD","TSLG","VT","LU0308772762.SGD","LU1804176565.USD","LU0198837287.USD","AGOX","IE0009G5SDU7.USD","LU1868836914.USD","SGXZ31699556.SGD","LU1232071149.USD","IE00BHPRN162.USD","LU2045819591.USD","GRAG","LU1037948897.HKD","IE00BYXW3230.USD","LU1267930730.SGD","TSII","EFIV","LU0174119429.USD","LU0648001328.SGD","LU0788109477.HKD","LU1720051108.HKD","LU0871640123.AUD","LU1861127337.USD","LU0572108347.SGD","LU1153585028.USD","SG9999002620.SGD","AALG","FDRV","SG9999004303.SGD","LU2065170008.USD","LU0689626769.HKD","THMR","IE00B7KXQ091.USD","SG9999015945.SGD","JETS","LU2417539215.USD","LU0353189763.USD","LU1883839398.USD","07788","LU0476273544.USD","LU0472753341.HKD","IE00BFSS8Q28.SGD","LU0787776722.HKD","IE0034235188.USD","LU1571399168.USD","LU2023250843.SGD","IE0004086264.USD","FTEC","LU1861220207.SGD","LU2272731782.SGD","IDRV","HK0000320264.USD","LU0957791311.USD","NVII","HK0000320223.HKD","TEK","LU2463028550.USD","LU0345774631.USD","LU1868836591.USD","LU1861559042.SGD","SG9999002679.SGD","LU1242518931.SGD","LU1244550577.SGD","LU0321505868.SGD","HULL","IE00B3S45H60.SGD","LU1974910355.USD","SOFC","ONLN","LU0203202063.USD","BK4547","IE00BJJMRY28.SGD","SOFX","LU2211817866.USD","LU2458330169.SGD","LU2360106780.USD","BK4581","BK4516","LU2065169927.USD","LU2361044865.SGD","INTC","NJAN","LU1880398554.USD","TBJL","IE00BYQQ9H92.USD","TSLY","LU2089283258.USD","LU2543165471.USD","LU0466842654.USD","AIS","BK4524","LU2106854487.HKD","LU2471134523.USD","QLD","IE00BK4W5M84.HKD","09086","LU0823414478.USD","XLK","LU1066053197.SGD","SG9999015978.USD","IE0003U64NQ7.SGD","BK4579","LU2552382215.SGD","BK4567","CHPS","LU0651946864.USD","TSLA","BK4512","LU1051768304.USD","LU2860962120.EUR","BK4612","CLIX","LU2746668461.USD","LU1201861165.SGD","LU1069347547.HKD","LU2756315664.SGD","IE00BJTD4N35.SGD","TSLR","BWZ","02834","LU0784385840.USD","GRAB","IEI","LU0097036916.USD","LU2065171311.SGD","HK0000532082.HKD","SG9999013486.USD","TLA","OGIG","BK4605","LU0225283273.USD","LU1814569148.SGD","LU2552382058.USD","LU0820562030.AUD","LU2237443978.SGD","SG9999015952.SGD","XP","SG9999014559.SGD","NDX","AMZY","LU2125909759.SGD","LU2237438978.USD","TSLS","LU2247934214.USD","IE00BKVL7J92.USD","07388","LU2286300806.USD","LU2125154935.USD","LU1839390173.USD","LU1988902786.USD","IE00B19Z3581.USD","LU0345770993.USD","LU1645745479.HKD","LU2413666699.HKD","BK4602","BK4141","LU0267386448.USD","SMOG","LU0208291251.USD","BK4139","HK0000819398.USD","IE000Q6AESB8.SGD","LU0158827948.USD","TSYY","GB00BDT5M118.USD","LU0070217475.USD","LU2242649171.HKD","BK4561","LU2362541273.HKD","TTXU","LU0158827781.USD","IE000KEQY171.SGD","NVDX","LU0784385170.HKD","LU1914381329.SGD","NJUL","LU2462591277.SGD","HK0000304797.USD","BK4533","LU0353189680.USD","LU1868837136.USD","LU0096362180.USD","LU0130103400.USD","LU0823434583.USD","SOFA","BK4614","TSLT","LU1301847155.USD","LU2764263203.CNY","LU1861215975.USD","LU0788109048.HKD","HK0000914660.USD","LU1917777945.USD","LU2100268510.USD","BK4604","FLGV","LU0642271901.SGD","LU2089284900.SGD","LU1791710582.SGD","LU1145028129.USD","SG9999002604.SGD","ISHG","LU1935043536.SGD","XTN","NVDS.UK","LU1267930490.SGD","SG9999002224.SGD","LU1923622291.USD","LU2602419157.SGD","09788","LU0138981039.USD","BK4551","LU1069344957.HKD","NVDS","SG9999013460.SGD","BK4575","LU0345768740.USD","LU0238689110.USD","LU2191332357.HKD","STSLAmain","NFXL","LU2244417387.USD","LU0154236417.USD","NAPR","LU1983260115.SGD","BK4108","SNVDAmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672102723","title":"Could Tempus RNA License Alter The Investment Case For Recursion Pharmaceuticals (RXRX)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672102723","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672102723?lang=en_us&edition=fundamental","pubTime":"2026-10-03 18:17","pubTimestamp":1791022629,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals disclosed a past TxFM License Agreement with Tempus AI that grants a two year, non exclusive, oncology focused RNA model license for US$12,000,000 and access to de identified pathology records with linked clinical data.\nThe combination of upfront cash and incremental oncology data directly affects how Recursion Pharmaceuticals funds its drug discovery work and refines its AI driven models.\nThis section examines how Recursion Pharmaceuticals' investment narrative is...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/could-tempus-rna-license-alter-the-investment-case-for-recur","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rxrx/recursion-pharmaceuticals/news/could-tempus-rna-license-alter-the-investment-case-for-recur","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4548","BK4609","BK4611","BK4539","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181200013","title":"One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model","url":"https://stock-news.laohu8.com/highlight/detail?id=1181200013","media":"AI Industry Frontlines","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181200013?lang=en_us&edition=fundamental","pubTime":"2026-10-03 18:15","pubTimestamp":1791022548,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3089.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3089.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVD","NVDU","LLY","NVDG","NVII","MSFX","GOGL","AIQ","NVDO","MSFY","GOOGL","LLYX","GOOW","NVOH","GOOL","ARKG","GOOX","DIPS","GGLL","GOU","NVDW","NVDL","NVDQ","07388","MSFL","RXRX","NVDB","NVDY","ANV","NVDA","NVS","SDGR","GGLS","JNJ","NVDD","NVOX","LLII","GOOY","07788","NVYY","ELIL","ELIS","NVO","GOOP","MSFW","NVDX","NVOC","MSFD","MSFO","NVC","IBB","NVDS","MSFC","MSFT","MSFU"],"isVideo":true,"video":{"duration":212,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/3089/render_3089_1791021487749.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3089.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/3089/tts/voiceover_b9d2a6cae7d8b2cb.mp3","isAI":true},"gpt_icon":0},{"id":"1124840365","title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1124840365","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124840365?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:11","pubTimestamp":1790932272,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3059.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIR","AZN","XBI","PFE","BEAM","TXG","NVOC","MRNA","GSKH","LLII","TEM","ABBV","GILD","NVO","DNA","ABT","SNY","SBIO","MRNX","VERU","GERM","REGN","JNJ","LLYX","NVOX","MRNY","AMGN","ELIL","BIIB","IDNA","NVOH","TEMT","LLY","BMY","RBOT","CRSP","ELIS","BNTX","RXRX","MRK","NVAX","NVS","ABSI","TEMC","GSK"],"isVideo":true,"video":{"duration":213,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3059.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","audio_url":"https://static.tigerbbs.com/1c89c593761ab28aabf1a552eb3a775b.mp3","isAI":true},"gpt_icon":0},{"id":"1120137912","title":"From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot","url":"https://stock-news.laohu8.com/highlight/detail?id=1120137912","media":"Tech News Roundup","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120137912?lang=en_us&edition=fundamental","pubTime":"2026-10-02 12:48","pubTimestamp":1790916487,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3039.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3039.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMC","TXG","CRSP","CHRN","RXRX","BEAM","RBOT","TEM","TEMT","ABSI","DNA"],"isVideo":true,"video":{"duration":176,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/3039/render_3039_1790915786173.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3039.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/3039/tts/voiceover_6b46a617ba2088f4.mp3","isAI":true},"gpt_icon":0},{"id":"2669162636","title":"Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162636","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162636?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:18","pubTimestamp":1790007493,"startTime":"0","endTime":"0","summary":"Recursion licenses TxFM RNA foundation model to Tempus AI for oncology use in USD 12 million dealRecursion Pharmaceuticals expanded its data partnership with Tempus AI, extending the term to six years","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL7Y7sX8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","BK4539","BK4548","BK4609","BK4611","TEMT","LU1861558580.USD","LU1861559042.SGD","RXRX","BK4139","BK4121","BK4613","TEM","HEAL","TEMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162688","title":"Tempus Extends Data Licensing Partnership with Recursion Through November 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162688","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162688?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:17","pubTimestamp":1790007444,"startTime":"0","endTime":"0","summary":"Tempus extends data licensing partnership with Recursion through November 2029Tempus extended its multi-year data license partnership with Recursion through November 2029.Deal resets original master a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL8vkn23:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4611","BK4613","HEAL","TEM","TEMC","TEMT","LU1861559042.SGD","RXRX","BK4609","LU1861558580.USD","BK4548","BK4121","BK4539","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669161540","title":"Tempus AI, Recursion Extend Data License, Amend Fee Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669161540","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669161540?lang=en_us&edition=fundamental","pubTime":"2026-09-21 22:36","pubTimestamp":1790001417,"startTime":"0","endTime":"0","summary":"Tempus AI  and Recursion Pharmaceuticals  extended their data license agreement through November 2029 and revised the contract's fee structure.Up to $84 million in discretionary payments over the next two years will be replaced with $42 million in committed payments over three years, Tempus said Monday in a statement.Tempus said it also signed a separate agreement granting the company a nonexclusive, worldwide license to Recursion's proprietary RNA sequencing model.Tempus shares rose 1.8% in Monday trading, and Recursion climbed 2.6%.Price: 79.27, Change: +1.43, Percent Change: +1.83","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4611","LU1861559042.SGD","BK4548","TEM","LU1861558580.USD","HEAL","BK4139","BK4609","TEMT","TEMC","ARKG","BK4613","RXRX","BK4121","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169875","title":"Recursion, Tempus Expand AI and RNA Collaboration Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169875","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169875?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:29","pubTimestamp":1789997370,"startTime":"0","endTime":"0","summary":"The latest update is out from Recursion Pharmaceuticals ( ($RXRX) ). On September 15, 2026, Recursion Pharmaceuticals amended its long-term data an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4613","BK4609","BK4611","LU1861558580.USD","TEMC","ARKG","HEAL","TEMT","BK4121","LU1861559042.SGD","RXRX","TEM","BK4548","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169889","title":"Tempus AI, Recursion extend data license agreement, enter new license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169889?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:20","pubTimestamp":1789996814,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced an extension of its data license agreement with Recursion Pharmaceuticals (RXRX). Additionally, the two companies have en...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARKG","LU1861559042.SGD","BK4121","TEMT","TEMC","LU1861558580.USD","BK4548","BK4539","BK4611","BK4613","TEM","HEAL","RXRX","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669666681","title":"Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm","url":"https://stock-news.laohu8.com/highlight/detail?id=2669666681","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669666681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4613","HEAL","TEMT","ARKG","BK4609","BK4539","TEM","RXRX","BK4121","BK4548","BK4139","LU1861559042.SGD","TEMC","LU1861558580.USD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166574","title":"Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s Rna Foundation Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166574?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4613","HEAL","TEMT","ARKG","BK4609","BK4539","TEM","RXRX","BK4121","BK4548","BK4139","LU1861559042.SGD","TEMC","LU1861558580.USD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166572","title":"Tempus AI, -Co and Recursion Extend Data Partnership Through November 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166572","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166572?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4613","HEAL","TEMT","ARKG","BK4609","BK4539","TEM","RXRX","BK4121","BK4548","BK4139","LU1861559042.SGD","TEMC","LU1861558580.USD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669663671","title":"Recursion Pharmaceuticals - Enters Amendment to Master Agreement with Tempus on Sept 15, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669663671","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669663671?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:06","pubTimestamp":1789995986,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4609","BK4611","BK4539","RXRX","BK4548"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.recursion.com;ir.recursion.com","stockEarnings":[{"period":"1week","weight":0.0339},{"period":"1month","weight":0.1763},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.3018},{"period":"1year","weight":-0.1836},{"period":"ytd","weight":0.044}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0091},{"period":"3month","weight":0.0339},{"period":"6month","weight":0.1439},{"period":"1year","weight":0.1616},{"period":"ytd","weight":0.1398}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 1b/2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer; REC-64151 for the treatment of immune checkpoint resistance; and Anti-PD-(L)1, an orally bioavailable small molecule to improve sensitivity to immune checkpoint inhibitors in non-small cell lung cancer and additional tumors. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Chromaderm, Inc.; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.035717},{"month":2,"riseRate":0.4,"avgChangeRate":0.049361},{"month":3,"riseRate":0,"avgChangeRate":-0.249219},{"month":4,"riseRate":0.4,"avgChangeRate":-0.090167},{"month":5,"riseRate":0.5,"avgChangeRate":0.076509},{"month":6,"riseRate":0.666667,"avgChangeRate":0.117519},{"month":7,"riseRate":0.666667,"avgChangeRate":0.141285},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.083252},{"month":9,"riseRate":0.5,"avgChangeRate":-0.006288},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.060324},{"month":11,"riseRate":0.4,"avgChangeRate":0.028843},{"month":12,"riseRate":0.2,"avgChangeRate":-0.000986}],"exchange":"NASDAQ","name":"Recursion Pharmaceuticals, Inc.","nameEN":"Recursion Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Recursion Pharmaceuticals, Inc.(RXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Recursion Pharmaceuticals, Inc.,RXRX,Recursion Pharmaceuticals, Inc.股票,Recursion Pharmaceuticals, Inc.股票老虎,Recursion Pharmaceuticals, Inc.股票老虎国际,Recursion Pharmaceuticals, Inc.行情,Recursion Pharmaceuticals, Inc.股票行情,Recursion Pharmaceuticals, Inc.股价,Recursion Pharmaceuticals, Inc.股市,Recursion Pharmaceuticals, Inc.股票价格,Recursion Pharmaceuticals, Inc.股票交易,Recursion Pharmaceuticals, Inc.股票购买,Recursion Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Recursion Pharmaceuticals, Inc.(RXRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Recursion Pharmaceuticals, Inc.(RXRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction